SynthesisOrphanet journal of rare diseases2022

A lack of race and ethnicity data in the treatment of hereditary hemorrhagic telangiectasia: a systematic review of intravenous bevacizumab efficacy.

Panagis Galiatsatos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.